CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Unaudited) - USD ($) $ in Thousands		Total		Ward Village Homeowners' Associations	Total Stockholders’ Equity	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests	Noncontrolling Interests Ward Village Homeowners' Associations
Balance at the beginning of the period (in shares) at Dec. 31, 2021						56,173,276
Balance at the beginning of the period at Dec. 31, 2021		$ 3,710,670			$ 3,709,995	$ 563	$ 3,960,418	$ (16,456)	$ (14,457)	$ (220,073)	$ 675
Balance at the beginning of the period (in shares) at Dec. 31, 2021										(2,107,615)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		131,272			131,782			131,782			(510)
Interest rate swaps, net of tax		31,064	[1]		31,064				31,064
Deconsolidation of Ward Village homeowners’ associations				$ (210)								$ (210)
Teravalis noncontrolling interest		65,046									65,046
Reclassification of the Company’s share of previously deferred derivative gains, net of tax expense	[2]	(6,723)			(6,723)				(6,723)
Repurchase of common shares (in shares)										(4,283,874)
Repurchase of common shares		(388,372)			(388,372)					$ (388,372)
Stock plan activity (in shares)						134,110				(14,896)
Stock plan activity		8,144			8,144	$ 1	9,422			$ (1,279)
Balance at the end of the period (in shares) at Sep. 30, 2022						56,307,386
Balance at the end of the period at Sep. 30, 2022		3,550,891			3,485,890	$ 564	3,969,840	115,326	9,884	$ (609,724)	65,001
Balance at the end of the period (in shares) at Sep. 30, 2022										(6,406,385)
Balance at the beginning of the period (in shares) at Jun. 30, 2022						56,295,548
Balance at the beginning of the period at Jun. 30, 2022		3,443,801			3,393,398	$ 564	3,967,194	7,230	2,362	$ (583,952)	50,403
Balance at the beginning of the period (in shares) at Jun. 30, 2022										(6,032,999)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		107,669			108,096			108,096			(427)
Interest rate swaps, net of tax		7,522	[1]		7,522				7,522
Teravalis noncontrolling interest		15,025									15,025
Repurchase of common shares (in shares)										(368,806)
Repurchase of common shares		(25,440)			(25,440)					$ (25,440)
Stock plan activity (in shares)						11,838				(4,580)
Stock plan activity		2,314			2,314		2,646			$ (332)
Balance at the end of the period (in shares) at Sep. 30, 2022						56,307,386
Balance at the end of the period at Sep. 30, 2022		$ 3,550,891			3,485,890	$ 564	3,969,840	115,326	9,884	$ (609,724)	65,001
Balance at the end of the period (in shares) at Sep. 30, 2022										(6,406,385)
Balance at the beginning of the period (in shares) at Dec. 31, 2022		49,801,997				56,226,273
Balance at the beginning of the period at Dec. 31, 2022		$ 3,606,112			3,540,499	$ 564	3,972,561	168,077	10,335	$ (611,038)	65,613
Balance at the beginning of the period (in shares) at Dec. 31, 2022		(6,424,276)								(6,424,276)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		$ (585,755)			(585,921)			(585,921)			166
Interest rate swaps, net of tax		(2,764)	[1]		(2,764)				(2,764)
Teravalis noncontrolling interest		177									177
Stock plan activity (in shares)						322,506				(21,628)
Stock plan activity		9,418			9,418	$ 2	11,138			$ (1,722)
Stock conversion to HHH (in shares)						(56,548,779)				6,445,904
Stock conversion to HHH		0				$ (566)	(612,194)			$ 612,760
HHC shares issued to HHH (in shares)						10
Capital transactions with HHH		2,485			2,485		2,623	(138)
Other		$ (22)									(22)
Balance at the end of the period (in shares) at Sep. 30, 2023		10				10
Balance at the end of the period at Sep. 30, 2023		$ 3,029,651			2,963,717	$ 0	3,374,128	(417,982)	7,571	$ 0	65,934
Balance at the end of the period (in shares) at Sep. 30, 2023		0								0
Balance at the beginning of the period (in shares) at Jun. 30, 2023						56,533,030
Balance at the beginning of the period at Jun. 30, 2023		$ 3,568,453			3,502,625	$ 566	3,980,780	126,189	7,753	$ (612,663)	65,828
Balance at the beginning of the period (in shares) at Jun. 30, 2023										(6,444,748)
Increase (Decrease) in Stockholders' Equity
Net income (loss)		(543,987)			(544,033)			(544,033)			46
Interest rate swaps, net of tax		(182)	[1]		(182)				(182)
Teravalis noncontrolling interest		60									60
Stock plan activity (in shares)						15,749				(1,156)
Stock plan activity		2,822			2,822		2,919			$ (97)
Stock conversion to HHH (in shares)						(56,548,779)				6,445,904
Stock conversion to HHH		0				$ (566)	(612,194)			$ 612,760
HHC shares issued to HHH (in shares)						10
Capital transactions with HHH		$ 2,485			2,485		2,623	(138)
Balance at the end of the period (in shares) at Sep. 30, 2023		10				10
Balance at the end of the period at Sep. 30, 2023		$ 3,029,651			$ 2,963,717	$ 0	$ 3,374,128	$ (417,982)	$ 7,571	$ 0	$ 65,934
Balance at the end of the period (in shares) at Sep. 30, 2023		0								0

[1] Amounts are shown net of tax benefit of $0.1 million for the three months ended September 30, 2023, and $0.8 million for the nine months ended September 30, 2023, and tax expense of $2.2 million for the three months ended September 30, 2022, and $9.3 million for the nine months ended September 30, 2022.

[2] In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 - Investments in Unconsolidated Ventures for additional information.